Craft
Orion

Orion

Revenue

€1 B

FY, 2021

Market Capitalization

€7 B

2022-11-28

Orion Summary

Company summary

Overview
Orion is a company that develops, manufactures, and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients, and diagnostic tests. It offers healthcare prescription drugs and other products for treatment and prevention of the commonest illnesses. The company also provides proprietary veterinary medicines and a wide range of generic medicines.
Type
Public
Status
Active
Founded
1917
HQ
Espoo, FI | view all locations
Website
https://www.orion.fi/en/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key people

  • Timo Lappalainen

    Timo Lappalainen, President and CEO

  • Jari Karlson

    Jari Karlson, Chief Financial Officer, Senior Vice President, Animal Health

  • Olli Huotari

    Olli Huotari, Senior Vice President, Corporate Functions, Secretary to the Board of Directors, General Counsel

    • Liisa Hurme

      Liisa Hurme, Senior Vice President, Global Operations, Chairman of the Board of Fermion

    LocationsView all

    25 locations detected

    • Espoo HQ

      Finland

      Orionintie 1A, P.O.Box 65

    • Wien, Wien

      Austria

      Turm A, Vienna Business Park

    • Mechelen, Vlaanderen

      Belgium

      Battelsesteenweg 455D

    • Shanghai

      China

      China Office, Fenghua Innovation Center Room 401, Building 2, 690 Bibo Road, Zhangjiang Hi-Tech Park

    • Praha, Hlavní město Praha

      Czech Republic

      Na Strži 2102/61a

    • København

      Denmark

      73 Ørestads Blvd.

    and 19 others

    Orion Financials

    Summary financials

    Revenue (Q3, 2022)
    €491.8M
    Gross profit (Q3, 2022)
    €369.9M
    Net income (Q3, 2022)
    €194.5M
    Cash (Q3, 2022)
    €367.1M
    EBIT (Q3, 2022)
    €245.5M
    Enterprise value
    $6.8B

    Footer menu